<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Hercules Capital Inc — News on 6ix</title>
<link>https://6ix.com/company/hercules-capital-inc</link>
<description>Latest news and press releases for Hercules Capital Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 Apr 2026 10:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/hercules-capital-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835801978dffbe2df0fb4d7.webp</url>
<title>Hercules Capital Inc</title>
<link>https://6ix.com/company/hercules-capital-inc</link>
</image>
<item>
<title>Hercules Capital Announces Date for Release of First Quarter 2026 Financial Results and Conference Call</title>
<link>https://6ix.com/company/hercules-capital-inc/news/hercules-capital-announces-date-for-release-of-first-quarter-2026-financial-results-and-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/hercules-capital-announces-date-for-release-of-first-quarter-2026-financial-results-and-conference-call</guid>
<pubDate>Tue, 21 Apr 2026 10:00:00 GMT</pubDate>
<description>SAN MATEO, Calif., April 21, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its first quarter 2026 financial results conference call for Tuesday, May 5, 2026, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will rel</description>
</item>
<item>
<title>Hercules Capital Sets New Record with All-Time High New Debt and Equity Commitments</title>
<link>https://6ix.com/company/hercules-capital-inc/news/hercules-capital-sets-new-record-with-all-time-high-new-debt-and-equity-commitments</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/hercules-capital-sets-new-record-with-all-time-high-new-debt-and-equity-commitments</guid>
<pubDate>Mon, 06 Apr 2026 10:00:00 GMT</pubDate>
<description>SAN MATEO, Calif., April 06, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced it has set a new all-time record of $1.81 billion in new debt and equity commitments for the first quarter of 2026.</description>
</item>
<item>
<title>enGene Reports First Quarter 2026 Financial Results and Provides Business Update</title>
<link>https://6ix.com/company/hercules-capital-inc/news/engene-reports-first-quarter-2026-financial-results-and-provides-business-update-1</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/engene-reports-first-quarter-2026-financial-results-and-provides-business-update-1</guid>
<pubDate>Mon, 09 Mar 2026 11:00:00 GMT</pubDate>
<description>BOSTON & MONTREAL, March 09, 2026--enGene Holdings Inc. (Nasdaq: ENGN, "enGene" or the "Company"), a clinical-stage, non-viral genetic medicines company, today announced its financial results for the first quarter ended January 31, 2026, and provided a business update.</description>
</item>
<item>
<title>Hercules Capital Receives a BBB (high) Affirmed Investment Grade Corporate and Credit Rating from Morningstar DBRS</title>
<link>https://6ix.com/company/hercules-capital-inc/news/hercules-capital-receives-a-bbb-high-affirmed-investment-grade-corporate-and-credit-rating-from-morningstar-dbrs</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/hercules-capital-receives-a-bbb-high-affirmed-investment-grade-corporate-and-credit-rating-from-morningstar-dbrs</guid>
<pubDate>Wed, 04 Mar 2026 17:16:00 GMT</pubDate>
<description>SAN MATEO, Calif., March 04, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Morningstar DBRS ("DBRS") has affirmed Hercules’ investment grade corporate and credit rating of BBB (high). DBRS issued a statement announcing the a</description>
</item>
<item>
<title>Hercules Capital Named 2025 Americas BDC Manager of the Year by Private Debt Investor</title>
<link>https://6ix.com/company/hercules-capital-inc/news/hercules-capital-named-2025-americas-bdc-manager-of-the-year-by-private-debt-investor</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/hercules-capital-named-2025-americas-bdc-manager-of-the-year-by-private-debt-investor</guid>
<pubDate>Mon, 02 Mar 2026 15:55:00 GMT</pubDate>
<description>SAN MATEO, Calif., March 02, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, was named 2025 BDC Manager of the Year - Americas by Private Debt Investor magazine.</description>
</item>
<item>
<title>Hercules Capital Reports Fourth Quarter and Full-Year 2025 Financial Results</title>
<link>https://6ix.com/company/hercules-capital-inc/news/hercules-capital-reports-fourth-quarter-210500513</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/hercules-capital-reports-fourth-quarter-210500513</guid>
<pubDate>Thu, 12 Feb 2026 21:05:00 GMT</pubDate>
<description>SAN MATEO, Calif., February 12, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the fourth quarter and full-year ended December 31, 2025. The earnings release can be accessed at Hercules’ Investor Relation</description>
</item>
<item>
<title>Hercules Capital Closes Institutional Notes Offering of $300.0 Million 5.350% Unsecured Notes due 2029</title>
<link>https://6ix.com/company/hercules-capital-inc/news/hercules-capital-closes-institutional-notes-180600119</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/hercules-capital-closes-institutional-notes-180600119</guid>
<pubDate>Tue, 10 Feb 2026 18:06:00 GMT</pubDate>
<description>SAN MATEO, Calif., February 10, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), today announced that it has closed an underwritten public offering of $300.0 million in aggregate principal amount of 5.350% notes due February 2029 (the "Notes").</description>
</item>
<item>
<title>Hercules Capital Announces New Supplemental Cash Distribution of $0.28 per Share</title>
<link>https://6ix.com/company/hercules-capital-inc/news/hercules-capital-announces-supplemental-cash-110100605</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/hercules-capital-announces-supplemental-cash-110100605</guid>
<pubDate>Tue, 10 Feb 2026 11:01:00 GMT</pubDate>
<description>SAN MATEO, Calif., February 10, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a new supplemental cash distribution of $0.28 per share, to be distributed equally over four quarters b</description>
</item>
<item>
<title>Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Fourth Quarter 2025</title>
<link>https://6ix.com/company/hercules-capital-inc/news/hercules-capital-declares-total-cash-110000073</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/hercules-capital-declares-total-cash-110000073</guid>
<pubDate>Tue, 10 Feb 2026 11:00:00 GMT</pubDate>
<description>SAN MATEO, Calif., February 10, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a fourth quarter 2025 total cash distribution of $0.47 per share. The following shows the key dates of</description>
</item>
<item>
<title>Hercules Capital Prices Institutional Notes Offering of $300.0 Million 5.350% Notes due 2029</title>
<link>https://6ix.com/company/hercules-capital-inc/news/hercules-capital-prices-institutional-notes-210500720</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/hercules-capital-prices-institutional-notes-210500720</guid>
<pubDate>Thu, 05 Feb 2026 21:05:00 GMT</pubDate>
<description>SAN MATEO, Calif., February 05, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" "Hercules Capital," or the "Company"), today announced that it has priced an underwritten public offering of $300.0 million in aggregate principal amount of 5.350% notes due February 2029 (the "Notes"). The closing of the transaction is subject to customary closing conditions and the Notes are expected to be delivered and paid for on February 10, 2026.</description>
</item>
<item>
<title>Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update</title>
<link>https://6ix.com/company/hercules-capital-inc/news/replimune-reports-fiscal-third-quarter-2026-financial-results-and-provides-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/replimune-reports-fiscal-third-quarter-2026-financial-results-and-provides-corporate-update</guid>
<pubDate>Tue, 03 Feb 2026 13:00:00 GMT</pubDate>
<description>April 10, 2026 Target Action Date for RP1 in Advanced MelanomaWOBURN, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for the fiscal third quarter ended December 31, 2025 and provided a business update. The Company's Biologics License Application (BLA) resubmission for RP1 (vusolimogene oderparepvec) in anti-PD-1 failed melanoma wa</description>
</item>
<item>
<title>Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2025 Financial Results and Conference Call</title>
<link>https://6ix.com/company/hercules-capital-inc/news/hercules-capital-announces-date-release-110000487</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/hercules-capital-announces-date-release-110000487</guid>
<pubDate>Thu, 29 Jan 2026 11:00:00 GMT</pubDate>
<description>SAN MATEO, Calif., January 29, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its fourth quarter and full-year 2025 financial results conference call for Thursday, February 12, 2026, at 2:00 p.m. PT (5:00 p.m</description>
</item>
<item>
<title>Tenpoint Therapeutics Secures $235 Million through Series B Stock Financing and Credit Facility to Accelerate Commercialization of YUVEZZI™</title>
<link>https://6ix.com/company/hercules-capital-inc/news/tenpoint-therapeutics-secures-dollar235-million-through-series-b-stock-financing-and-credit-facility-to-accelerate-commercialization-of-yuvezzitm</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/tenpoint-therapeutics-secures-dollar235-million-through-series-b-stock-financing-and-credit-facility-to-accelerate-commercialization-of-yuvezzitm</guid>
<pubDate>Thu, 29 Jan 2026 03:15:00 GMT</pubDate>
<description>LONDON & SEATTLE, January 29, 2026--Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced it has secured $235 million through the successful close of its Series B preferred stock financing and a credit facility.</description>
</item>
<item>
<title>Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI*</title>
<link>https://6ix.com/company/hercules-capital-inc/news/savara-announces-amendment-to-hercules-capital-debt-facility-providing-up-to-dollar75m-of-additional-debt-funding-upon-us-food-and-drug-administration-fda-approval-of-molbreevi</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/savara-announces-amendment-to-hercules-capital-debt-facility-providing-up-to-dollar75m-of-additional-debt-funding-upon-us-food-and-drug-administration-fda-approval-of-molbreevi</guid>
<pubDate>Tue, 27 Jan 2026 13:05:00 GMT</pubDate>
<description>LANGHORNE, Pa., January 27, 2026--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the amendment of its loan and security agreement with Hercules Capital, Inc. (NYSE:HTGC), strengthening its balance sheet and liquidity.</description>
</item>
<item>
<title>enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.</title>
<link>https://6ix.com/company/hercules-capital-inc/news/engene-announces-expanded-dollar125-million-debt-facility-with-hercules-capital-inc</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/engene-announces-expanded-dollar125-million-debt-facility-with-hercules-capital-inc</guid>
<pubDate>Tue, 20 Jan 2026 22:35:00 GMT</pubDate>
<description>BOSTON & MONTREAL, January 20, 2026--enGene Holdings Inc. (Nasdaq: ENGN, "enGene" or the "Company"), a clinical-stage, non-viral genetic medicines company, today announced that it has entered into an amendment to an amended and restated loan and security agreement (as amended, the "Loan Agreement") with two of its subsidiaries and Hercules Capital, Inc. (NYSE: HTGC) ("Hercules"), as agent, for up to US$125 million. Access to the additional non-dilutive capital strengthens enGene’s balance sheet</description>
</item>
<item>
<title>HawkEye 360 Closes Strategic Acquisition and Secures Series E Preferred and Debt</title>
<link>https://6ix.com/company/hercules-capital-inc/news/hawkeye-360-closes-strategic-acquisition-and-secures-series-e-preferred-and-debt</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/hawkeye-360-closes-strategic-acquisition-and-secures-series-e-preferred-and-debt</guid>
<pubDate>Thu, 18 Dec 2025 17:19:00 GMT</pubDate>
<description>HawkEye 360, the global leader in signals intelligence data and analytics, today announced the completion of its acquisition of Innovative Signal Analysis (ISA), supported by equity and debt financings totaling $150 million.</description>
</item>
<item>
<title>Hercules Capital Announces Upcoming Event for the Financial Community</title>
<link>https://6ix.com/company/hercules-capital-inc/news/hercules-capital-announces-upcoming-event-110000238</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/hercules-capital-announces-upcoming-event-110000238</guid>
<pubDate>Tue, 11 Nov 2025 11:00:00 GMT</pubDate>
<description>SAN MATEO, Calif., November 11, 2025--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that members of the executive management team will be participating at the following event for the financial community:</description>
</item>
<item>
<title>Hercules Capital Reports Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/hercules-capital-inc/news/hercules-capital-reports-third-quarter-200500724</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/hercules-capital-reports-third-quarter-200500724</guid>
<pubDate>Thu, 30 Oct 2025 20:05:00 GMT</pubDate>
<description>SAN MATEO, Calif., October 30, 2025--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the third quarter ended September 30, 2025. The earnings release can be accessed at Hercules’ Investor Relations website at ht</description>
</item>
<item>
<title>Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Third Quarter 2025</title>
<link>https://6ix.com/company/hercules-capital-inc/news/hercules-capital-declares-total-cash-100000223</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/hercules-capital-declares-total-cash-100000223</guid>
<pubDate>Tue, 28 Oct 2025 10:00:00 GMT</pubDate>
<description>SAN MATEO, Calif., October 28, 2025--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty finance provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a third quarter 2025 total cash distribution of $0.47 per share. The following shows the key dates of the</description>
</item>
<item>
<title>Hercules Capital Celebrates $25.0 Billion Milestone in Total Cumulative Debt Commitments</title>
<link>https://6ix.com/company/hercules-capital-inc/news/hercules-capital-celebrates-25-0-100000846</link>
<guid isPermaLink="true">https://6ix.com/company/hercules-capital-inc/news/hercules-capital-celebrates-25-0-100000846</guid>
<pubDate>Mon, 27 Oct 2025 10:00:00 GMT</pubDate>
<description>SAN MATEO, Calif., October 27, 2025--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is celebrating reaching the $25.0 billion milestone in total cumulative debt commitments since its first origination in October 2004.</description>
</item>
</channel>
</rss>